Position Statement: Accessibility of Gene Therapy for Thalassaemia
- Version
- Download 2656
- File Size 541.40 KB
- File Count 1
- Create Date April 27, 2021
- Last Updated July 6, 2021
Position Statement: Accessibility of Gene Therapy for Thalassaemia
Gene therapy has been a long-awaited scientific development for thalassaemia patients and has given
hope, optimism, and opened new horizons. It is imperative for ground-breaking scientific advances and innovative therapies to be sufficiently recognized by national health authorities in conjunction with not only an understanding of the impact of the disease on the daily lives of patients and their families but also in regards to the actual cost-of-illness for healthcare providers.
Attached Files
TIF_GT_Germany_210426.pdf
